{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-25-000056","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2025-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.341211+00:00","generated_at":"2026-05-17T11:19:59.582112+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Edwards Lifesciences announces $500M accelerated share repurchase, initial ~5M shares","bullets":["$500M accelerated share repurchase executed; initial delivery of ~5 million shares.","Total 2025 share repurchases exceed $800 million; $600M remains under authorization.","Funded with existing cash; final share count based on VWAP during ASR term."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-25-000056","json":"https://secwatch.observer/filing/0001099800-25-000056.json","markdown":"https://secwatch.observer/filing/0001099800-25-000056.md","text":"https://secwatch.observer/filing/0001099800-25-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980025000056/0001099800-25-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980025000056/ew-20250819.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:19:59.582112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}